Skip to content

The comparison in development of wound bed granulation of topical oxygen therapy during negative pressure wound therapy to conventional negative pressure wound therapy in successful ischemic wound revascularized patients; A Randomized Clinical Trial.

The comparison in development of wound bed granulation of topical oxygen therapy during negative pressure wound therapy to conventional negative pressure wound therapy in successful ischemic wound revascularized patients; A Randomized Clinical Trial.

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230504001
Enrollment
30
Registered
2023-05-04
Start date
2023-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic limb threatening ischemia and ischemic wound Negative pressure wound therapy Topical oxygen therapy Ischemic foot ulcer Chronic limb threatening ischemia Revascularization Granulation tissue

Interventions

1 Adequate pain control and wound debridement. 2 Standard negative pressure wound therapy at pressure -75 mmHg with a-sterile tube connected to O2 supplier with O2 flow 3 L per min for daily 90 min pe
Experimental Device,Placebo Comparator Device
Topical oxygen therapy,Standard negative pressure wound therapy

Sponsors

Rajavithi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients were diagnosed Chronic limb threatening ischemia with ischemic foot ulcer 2.Successful below knee revascularization at least 2 of 3 vessels such as anterior tibial artery , posterior tibial artery, pernoneal artery. 3. Age more than 18 years old 4. Pre-treatment serum albumin more than 3 gram/dL

Exclusion criteria

Exclusion criteria: 1. Patients do not have contraindication for endovascular revascularization 2. Unsuccessful revascularized patients or successful revascularization only 1 of 3 vessels. 3. Patients who was performed a major amputation (ex. below knee amputation or above knee amputation) of index limb. 4. Patients with combined chronic arterial and venous insufficiency. 5. Patients who is taking the steriod drugs, immunosuppressive drugs or antineoplastic drugs.

Design outcomes

Primary

MeasureTime frame
Time to complete wound granulation tissue at the time wound bed is filled with granulation tissue full wound bed granulation tissue

Secondary

MeasureTime frame
Wound size reduction from start treatment to the complete research study. (at least 12 weeks of follow up.) Wound area is equal to longest width x length,Complete wound healing time from start treatment to the complete research study (at least 12 weeks of follow up.) Time from start treatment to complete wound epithelialization,Hospitalization time from start treatment to the complete research study (at least 12 weeks of follow up). total days of hospitalization which associated with wound care.,Limb salvage from start treatment to complete research study (at least 12 weeks of follow up) Number of limb salvage during reseach,Wound recurrence after discharge from hospital to the complete reseach study. (at least 12 weeks follow up) Wound recurrence at the same area of healed or complete granulation wound in the index limb,Wound complication from start treatment to complete research study (at least 12 weeks) the complications related to the index wound such as wound infection (confirmed by culture), wound edge marceration, wound necrosis confirmed by expert clinician.

Countries

Thailand

Contacts

Public ContactNAPAT SARAYUTPITAK

Rajavithi hospital

sarayutpitak.n45@gmail.com0805392381

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026